The skeleton and bone marrow microenvironment within bone acts as a critical organ for the development and spread of metastatic cancer. Bone metastases are common and have major impact on the physical function and quality of life of cancer patients. Over the last decade, as our understanding of the processes involved in metastasis has increased, it has become clear that bone marrow derived stem cells are intimately involved in the development of metastases both within and outside bone, and interactions between cancer and bone cells underpin the development of skeletal metastases. Additionally, as survival in many cancers improves, the long-term effects of treatment on bone health are of increasing importance.
Preclinical models of metastasis. The bone microenvironment in cancer and the role of stem cell, bone cell and cancer cell interactions in the development and spread of malignancy.
The pharmacology, therapeutic targets, drug development, clinical trials, side-effects, and health economics of bone targeted therapy. We are delighted, in partnership with Elsevier, to bring you this first issue of the Journal of Bone Oncology. Initially, 4 issues a year will be published and be made available via Science Direct. Our vision is to provide a journal to scientists and clinicians that bridges oncology and bone biology and is of broad appeal to all involved in cancer research and treatment. We do hope you will want to help make this journal a success by submitting relevant original research articles, review articles, editorials, case reports and opinion pieces.
